Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications
Open accessThe DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Radiation-based therapies aided by nanoparticles have been developed for decades, and can be primarily categorized into two main platforms. First, delivery of payload of photo-reactive drugs (photosensitizers) using the conventional nanoparticles, and second, design and development of photo-triggerable nanoparticles (primarily liposomes) to attain light-assisted on-demand drug delivery. The main focus of this review is to provide an update of the history, current status and future applications of photo-triggerable lipid-based nanoparticles (light-sensitive liposomes). We will begin with a brief overview on the applications of liposomes for delivery of photosensitizers, including the choice of photosensitizers for photodynamic therapy, as well as the currently available light sources (lasers) used for these applications. The main segment of this review will encompass the details of strategies used to develop photo-triggerable liposomes for their drug delivery function. The principles underlying the assembly of photoreactive lipids into nanoparticles (liposomes) and photo-triggering mechanisms will be presented. We will also discuss factors that limit the applications of these liposomes for in vivo triggered drug delivery and emerging concepts that may lead to the biologically viable photo-activation strategies. We will conclude with our view point on the future perspectives of light-sensitive liposomes in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282 · cited 1×
“…feature multifunctional nanoparticles with imaging molecules, a pay-load of drugs, targeting ligands, destabilization elements as well as sensors that probe the efficacy of the drug in real time (Allen & Cullis 2004, Alonso 2004, Torchilin 2005, Alaouie & Sofou 2008, Ganta et al. 2008, Zhou 2008).”
BackgroundDrug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233 · cited 1×
“…notable to mention that Doxil/caylex (a liposome-based formulation of an anticancer drug Doxorubicin, OrthoBiotech), was the first formulation approved for its application in the clinic and hence may be regarded as an honorary nanoparticle for patient care (Batist et al. 2001, Davis et al. 2008).”
BackgroundGomer, C. J. (1988) · Cited by 4,174
Surface Plasmon Spectroscopy of Nanosized Metal Particles
Mulvaney, P. (1996) · Langmuir · doi:10.1021/la9502711 · Cited by 3,681 · cited 1×
“AuNSTs exhibit surface plasmon resonance (Mulvaney 1996), as they absorb energy at a characteristic wavelength.”
BackgroundNanoparticle-mediated cellular response is size-dependent
Jiang, W., Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.30 · Cited by 2,776 · cited 1×
“…be customized in the range of 2–100 nm and their surface properties are amenable to the introduction of functional groups for conjugation of targeting ligands (Tkachenko et al. 2004, Souza et al. 2006, Berry et al. 2007, Oyelere et al. 2007, Jiang et al. 2008, Nativo et al. 2008) (see Table II).”
BackgroundA review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155 · cited 1×
“…feature multifunctional nanoparticles with imaging molecules, a pay-load of drugs, targeting ligands, destabilization elements as well as sensors that probe the efficacy of the drug in real time (Allen & Cullis 2004, Alonso 2004, Torchilin 2005, Alaouie & Sofou 2008, Ganta et al. 2008, Zhou 2008).”
BackgroundShedding light onto live molecular targets
Weissleder, R., & Ntziachristos, V. (2003) · Nature Medicine · doi:10.1038/nm0103-123 · Cited by 1,909 · cited 16×
“Since the 1980s, photodynamic therapy (PDT) has served as a promising treatment protocol and involves the use of a photosensitizing agent coupled with an appropriate light source.”
BackgroundInfluentialShukla, R., Bansal, V., Chaudhary, M., Basu, A., Bhonde, R. R., & Sastry, M. (2005) · Langmuir · doi:10.1021/la0513712 · Cited by 1,687 · cited 1×
“…may serve as good tools for in vivo cell imaging, biosensing, and drug and/or gene delivery (Markowitz et al. 1999, Sandhu et al. 2002, Sokolov et al. 2003, Regev et al. 2004, Shukla et al. 2005, Bergen et al. 2006a, Han et al. 2006, Kneipp et al. 2006, Kumar et al. 2007, Chithrani et al. 2010).”
Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., & Redemann, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,620 · cited 3×
“In addition, preferential uptake of liposomes by the reticuloendothelial system (RES) limited their in vivo applications (Papahadjopoulos et al. 1991, Gabizon & Martin 1997).”
BackgroundMethodChemical catalysis by colloids and clusters
Lewis, L. N. (1993) · Chemical Reviews · doi:10.1021/cr00024a006 · Cited by 1,438 · cited 1×
“…ions as alternate strategies for phototriggering of liposomes Nanostructures bearing noble metals are considered smart choices for targeting, and imaging because their properties deviate from the bulkmaterials (Lewis 1993, Klabunde et al. 1996, Pileni 2001, Schmid et al. 1999, Weller & Moser 1999).”
BackgroundThermal effect limits in ultrahigh-density magnetic recording
Weller, D., & Moser, A. (1999) · IEEE Transactions on Magnetics · doi:10.1109/20.809134 · Cited by 1,226 · cited 1×
“…ions as alternate strategies for phototriggering of liposomes Nanostructures bearing noble metals are considered smart choices for targeting, and imaging because their properties deviate from the bulkmaterials (Lewis 1993, Klabunde et al. 1996, Pileni 2001, Schmid et al. 1999, Weller & Moser 1999).”
BackgroundRobertson, C. A., Evans, D. H., & Abrahamse, H. (2009) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2009.04.001 · Cited by 1,198 · cited 1×
“In animalmodels, tumour regression is welldocumented using PDT, which presumably occurs by killing of cells, damage to tumour vasculature, and/or stimulation of immune responses that cause cell death (Juarranz et al 2008, Robertson et al. 2009).”
BackgroundLipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069 · cited 2×
“We have recently provided a detailed overview of lipid-based nanoparticles elsewhere (Puri et al. 2009).”
BackgroundMethodSelf-citationChen, J., Wang, D., Xi, J., Au, L., Siekkinen, A., Warsen, A., Li, Z.-Y., Zhang, H., Xia, Y., & Li, X. (2007) · Nano Letters · doi:10.1021/nl070345g · Cited by 1,025 · cited 1×
“However, near IR-based liposome-AuNP systems have not been fully explored presumably due to the technical limitations in synthesizing AuNPs particles susceptible to near IR light sources (Chen et al. 2007).”
BackgroundHaran, G., Cohen, R., Bar, L. K., & Barenholz, Y. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90105-9 · Cited by 934 · cited 1×
“…al. 1991, Gabizon & Martin 1997), and (ii) successful development of a remote drug loading process based on ammonium sulfate gradient method to achieve significantly high quantities of doxorubicin (as well as other weak bases) in the interior of the liposomes (Haran et al. 1993, Haran et al. 1994).”
MethodSokolov, K., Follen, M. M., Aaron, J., Pavlova, I., Malpica, A. L., Lotan, R., & Richards-Kortum, R. R. (2003) · PubMed · Cited by 838
Targeted pharmaceutical nanocarriers for cancer therapy and imaging
Torchilin, V. P. (2007) · The AAPS Journal · doi:10.1208/aapsj0902015 · Cited by 762 · cited 1×
“Nano-drug delivery systems coupled with site-specific targeting ligands constitute a promising system to boost efficacy and bioavailability of existing drugs and pharmaceuticals (Allen 1997, Allen & Cullis 2004, Torchilin 2007, Yang et al. 2007, Wang et al. 2009).”
BackgroundPhotodynamic therapy of cancer. Basic principles and applications
Juarranz, Á., Jaén, P., Sanz-Rodríguez, F., Cuevas, J., & González, S. (2008) · Clinical and Translational Oncology · doi:10.1007/s12094-008-0172-2 · Cited by 762 · cited 3×
“In animalmodels, tumour regression is welldocumented using PDT, which presumably occurs by killing of cells, damage to tumour vasculature, and/or stimulation of immune responses that cause cell death (Juarranz et al 2008, Robertson et al. 2009).”
BackgroundBatist, G., Ramakrishnan, G., Rao, C. S., Chandrasekharan, A., Gutheil, J., Guthrie, T., Shah, P., Khojasteh, A., Nair, M. K., Hoelzer, K., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1444 · Cited by 669 · cited 1×
“…notable to mention that Doxil/caylex (a liposome-based formulation of an anticancer drug Doxorubicin, OrthoBiotech), was the first formulation approved for its application in the clinic and hence may be regarded as an honorary nanoparticle for patient care (Batist et al. 2001, Davis et al. 2008).”
BackgroundUptake and Intracellular Fate of Surface-Modified Gold Nanoparticles
Nativo, P., Prior, I. A., & Brust, M. (2008) · ACS Nano · doi:10.1021/nn800330a · Cited by 659 · cited 1×
“…be customized in the range of 2–100 nm and their surface properties are amenable to the introduction of functional groups for conjugation of targeting ligands (Tkachenko et al. 2004, Souza et al. 2006, Berry et al. 2007, Oyelere et al. 2007, Jiang et al. 2008, Nativo et al. 2008) (see Table II).”
BackgroundNanocrystals as Stoichiometric Reagents with Unique Surface Chemistry
Klabunde, K. J., Stark, J., Koper, O., Mohs, C., Park, D. G., Decker, S., Jiang, Y., Lagadic, I., & Zhang, D. (1996) · The Journal of Physical Chemistry · doi:10.1021/jp960224x · Cited by 611 · cited 1×
“…ions as alternate strategies for phototriggering of liposomes Nanostructures bearing noble metals are considered smart choices for targeting, and imaging because their properties deviate from the bulkmaterials (Lewis 1993, Klabunde et al. 1996, Pileni 2001, Schmid et al. 1999, Weller & Moser 1999).”
BackgroundNeedham, D., & Dewhirst, M. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00233-2 · Cited by 570 · cited 1×
“It is important to note that thermosensitive liposomes (currently in Phase 3 clinical trials and first described in the late 1970s) are thus far the best studied example of triggerable nanoparticles (Needham & Dewhirst 2001, Negussie et al. 2010).”
BackgroundPeetla, C., Stine, A., & Labhasetwar, V. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9000662 · Cited by 559
The Role of Metal Nanoparticles in Remote Release of Encapsulated Materials
Skirtach, A. G., Dejugnat, C., Braun, D., Susha, A. S., Rogach, A. L., Parak, W. J., Möhwald, H., & Sukhorukov, G. B. (2005) · Nano Letters · doi:10.1021/nl050693n · Cited by 532 · cited 1×
“Near IR-based drug release (using the AuNP) has been demonstrated for polymeric carriers (Radt et al. 2004, Goodwin et al. 2005, Skirtach et al. 2005, Das et al. 2007), and these systems are currently in the developmental stage (Portney & Ozkan 2006).”
BackgroundLight‐sensitive Intelligent Drug Delivery Systems†
Alvarez‐Lorenzo, C., Bromberg, L., & Concheiro, A. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00530.x · Cited by 519
Photoluminescence from nanosize gold clusters
Wilcoxon, J. P., Martin, J. E., Parsapour, F., Wiedenman, B., & Kelley, D. F. (1998) · The Journal of Chemical Physics · doi:10.1063/1.476360 · Cited by 507 · cited 1×
“Most of the absorbed energy is converted to heat while a part of it is emitted as photoluminescence (Wilcoxon et al. 1998, Harris et al. 2006).”
BackgroundRemotely Triggered Liposome Release by Near-Infrared Light Absorption via Hollow Gold Nanoshells
Wu, G., Mikhailovsky, A., Khant, H. A., Fu, C., Chiu, W., & Zasadzinski, J. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802656d · Cited by 500 · cited 2×
“Therefore, light-induced heating of AuNSTs -liposome systems by UV, visible and near-infrared to release liposome-entrapped drugs and pharmaceuticals is drawing considerable interest (Paasonen et al. 2007, Wu et al. 2008a, Anderson et al. 2010).”
BackgroundMethodDendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging
Tomalia, D. A., Reyna, L. A., & Svenson, S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350061 · Cited by 496 · cited 1×
“Some widely examined nanocarriers aimed at delivering either DNA, pharmaceuticals and/or imaging agents include dendrimers (Tomalia et al. 2007, Majoros et al. 2008), nano-gold shells (Liao 2007, Bakri et al. 2008), nanoemulsions (Tiwari & Amiji 2006), drug-polymer conjugates (Reddy & Low 1998,…”
BackgroundRecent advances in tumor-targeting anticancer drug conjugates
Jaracz, S., Chen, J., Kuznetsova, L. V., & Ojima, I. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.084 · Cited by 490 · cited 2×
“…et al. 2008), nano-gold shells (Liao 2007, Bakri et al. 2008), nanoemulsions (Tiwari & Amiji 2006), drug-polymer conjugates (Reddy & Low 1998, Leamon & Low 2001), drug-antibody conjugates (Jaracz et al. 2005), and quantum dots (Cormode et al. 2009, Park et al. 2009, Rzigalinski & Strobl 2009).”
BackgroundGabizon, A., & Martin, F. (1997) · Drugs · doi:10.2165/00003495-199700544-00005 · Cited by 478 · cited 3×
“In addition, preferential uptake of liposomes by the reticuloendothelial system (RES) limited their in vivo applications (Papahadjopoulos et al. 1991, Gabizon & Martin 1997).”
BackgroundMethodIn Vivo Molecular Probing of Cellular Compartments with Gold Nanoparticles and Nanoaggregates
Kneipp, J., Kneipp, H., McLaughlin, M., Brown, D., & Kneipp, K. (2006) · Nano Letters · doi:10.1021/nl061517x · Cited by 472 · cited 1×
“…may serve as good tools for in vivo cell imaging, biosensing, and drug and/or gene delivery (Markowitz et al. 1999, Sandhu et al. 2002, Sokolov et al. 2003, Regev et al. 2004, Shukla et al. 2005, Bergen et al. 2006a, Han et al. 2006, Kneipp et al. 2006, Kumar et al. 2007, Chithrani et al. 2010).”
MethodNano-oncology: drug delivery, imaging, and sensing
Portney, N. G., & Ozkan, M. (2006) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-005-0247-7 · Cited by 456 · cited 1×
“Near IR-based drug release (using the AuNP) has been demonstrated for polymeric carriers (Radt et al. 2004, Goodwin et al. 2005, Skirtach et al. 2005, Das et al. 2007), and these systems are currently in the developmental stage (Portney & Ozkan 2006).”
BackgroundTkachenko, A. G., Xie, H., Liu, Y., Coleman, D., Ryan, J., Glomm, W. R., Shipton, M. K., Franzen, S., & Feldheim, D. L. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034189q · Cited by 448 · cited 1×
“…be customized in the range of 2–100 nm and their surface properties are amenable to the introduction of functional groups for conjugation of targeting ligands (Tkachenko et al. 2004, Souza et al. 2006, Berry et al. 2007, Oyelere et al. 2007, Jiang et al. 2008, Nativo et al. 2008) (see Table II).”
BackgroundLong-circulating (sterically stabilized) liposomes for targeted drug delivery
Allen, T. M. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90314-x · Cited by 445 · cited 1×
“The inclusion of PEG-lipids within the liposomes also greatly enhances their efficacy and biodistribution through the avoidance of the reticuloendothelial system (Allen 1994).”
BackgroundGold Nanoparticle-Mediated Transfection of Mammalian Cells
Sandhu, K. K., McIntosh, C. M., Simard, J. M., Smith, S. W., & Rotello, V. M. (2002) · Bioconjugate Chemistry · doi:10.1021/bc015545c · Cited by 430 · cited 1×
“…biocompatible and, therefore, may serve as good tools for in vivo cell imaging, biosensing, and drug and/or gene delivery (Markowitz et al. 1999, Sandhu et al. 2002, Sokolov et al. 2003, Regev et al. 2004, Shukla et al. 2005, Bergen et al. 2006a, Han et al. 2006, Kneipp et al. 2006, Kumar et…”
BackgroundCurrent and future applications of nanoclusters
Schmid, G., Bäumle, M., Geerkens, M., Heim, I., Osemann, C., & Sawitowski, T. (1999) · Chemical Society Reviews · doi:10.1039/a801153b · Cited by 409 · cited 1×
“…ions as alternate strategies for phototriggering of liposomes Nanostructures bearing noble metals are considered smart choices for targeting, and imaging because their properties deviate from the bulkmaterials (Lewis 1993, Klabunde et al. 1996, Pileni 2001, Schmid et al. 1999, Weller & Moser 1999).”
BackgroundOptically Addressable Nanostructured Capsules
Radt, B., Smith, T. A., & Caruso, F. (2004) · Advanced Materials · doi:10.1002/adma.200400920 · Cited by 404 · cited 1×
“Near IR-based drug release (using the AuNP) has been demonstrated for polymeric carriers (Radt et al. 2004, Goodwin et al. 2005, Skirtach et al. 2005, Das et al. 2007), and these systems are currently in the developmental stage (Portney & Ozkan 2006).”
BackgroundFolate-mediated targeting: from diagnostics to drug and gene delivery
Leamon, C. P., & Low, P. S. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01594-4 · Cited by 375
Magnetic Fluids: Fabrication, Magnetic Properties, and Organization of Nanocrystals
Pileni, M.-P. (2001) · Advanced Functional Materials · doi:10.1002/1616-3028(200110)11:5<323::aid-adfm323>3.0.co;2-j · Cited by 373 · cited 1×
“…ions as alternate strategies for phototriggering of liposomes Nanostructures bearing noble metals are considered smart choices for targeting, and imaging because their properties deviate from the bulkmaterials (Lewis 1993, Klabunde et al. 1996, Pileni 2001, Schmid et al. 1999, Weller & Moser 1999).”
BackgroundSynthetic Micelle Sensitive to IR Light via a Two-Photon Process
Goodwin, A. P., Mynar, J. L., Ma, Y., Fleming, G. R., & Fréchet, J. M. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0523035 · Cited by 352 · cited 1×
“Near IR-based drug release (using the AuNP) has been demonstrated for polymeric carriers (Radt et al. 2004, Goodwin et al. 2005, Skirtach et al. 2005, Das et al. 2007), and these systems are currently in the developmental stage (Portney & Ozkan 2006).”
BackgroundPeptide-Conjugated Gold Nanorods for Nuclear Targeting
Oyelere, A. K., Chen, P. C., Huang, X., El-Sayed, I. H., & El-Sayed, M. A. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070132i · Cited by 348 · cited 1×
“…be customized in the range of 2–100 nm and their surface properties are amenable to the introduction of functional groups for conjugation of targeting ligands (Tkachenko et al. 2004, Souza et al. 2006, Berry et al. 2007, Oyelere et al. 2007, Jiang et al. 2008, Nativo et al. 2008) (see Table II).”
BackgroundCadmium-containing nanoparticles: Perspectives on pharmacology and toxicology of quantum dots☆
Rzigalinski, B. A., & Strobl, J. S. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.04.010 · Cited by 345
Microimplosions: Cavitation Collapse and Shock Wave Emission on a Nanosecond Time Scale
Pecha, R., & Gompf, B. (2000) · Physical Review Letters · doi:10.1103/physrevlett.84.1328 · Cited by 326 · cited 1×
“Since irradiation of HGNs is likely to produce localized heating within the vicinity of HGN, this temperature gradient was proposed to produce unstable vapor microbubbles leading to transient cavitation by the mechanical and thermal effects (Pecha & Gompf 2000, Popinet & Zaleski 2002).”
BackgroundTailoring the Polyelectrolyte Coating of Metal Nanoparticles
Gittins, D. I., & Caruso, F. (2001) · The Journal of Physical Chemistry B · doi:10.1021/jp0111665 · Cited by 318 · cited 1×
“…(AuNP/HGNs) can be encapsulated into other nanoparticles such as liposomes (Markowitz et al. 1999, Faure et al. 2003, Regev et al. 2004, Park et al. 2006) and polymeric matrices (Mayer & Mark 1997, Cole et al. 1999, Gittins & Caruso 2001) making them suitable for biological applications.”
BackgroundNanomedicines for overcoming biological barriers
José Alonso, M. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.01.007 · Cited by 312 · cited 1×
“…feature multifunctional nanoparticles with imaging molecules, a pay-load of drugs, targeting ligands, destabilization elements as well as sensors that probe the efficacy of the drug in real time (Allen & Cullis 2004, Alonso 2004, Torchilin 2005, Alaouie & Sofou 2008, Ganta et al. 2008, Zhou 2008).”
BackgroundLight‐Regulated Release of DNA and Its Delivery to Nuclei by Means of Photolabile Gold Nanoparticles
Han, G., You, C., Kim, B., Turingan, R. S., Forbes, N. S., Martin, C. T., & Rotello, V. M. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600214 · Cited by 296 · cited 1×
“…may serve as good tools for in vivo cell imaging, biosensing, and drug and/or gene delivery (Markowitz et al. 1999, Sandhu et al. 2002, Sokolov et al. 2003, Regev et al. 2004, Shukla et al. 2005, Bergen et al. 2006a, Han et al. 2006, Kneipp et al. 2006, Kumar et al. 2007, Chithrani et al. 2010).”
MethodGabizón, A., & Martin, F. J. (1997) · Drugs · Cited by 293
Liposomen: Möglichkeiten der Medikamentenfreisetzung
Allen, T. M. (1997) · Drugs · doi:10.2165/00003495-199700544-00004 · Cited by 279 · cited 1×
“Nano-drug delivery systems coupled with site-specific targeting ligands constitute a promising system to boost efficacy and bioavailability of existing drugs and pharmaceuticals (Allen 1997, Allen & Cullis 2004, Torchilin 2007, Yang et al. 2007, Wang et al. 2009).”
BackgroundNanotechnology in Medical Imaging: Probe Design and Applications
Cormode, D. P., Skajaa, T., Fayad, Z. A., & Mulder, W. J. M. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.165506 · Cited by 275 · cited 1×
“…et al. 2008), nano-gold shells (Liao 2007, Bakri et al. 2008), nanoemulsions (Tiwari & Amiji 2006), drug-polymer conjugates (Reddy & Low 1998, Leamon & Low 2001), drug-antibody conjugates (Jaracz et al. 2005), and quantum dots (Cormode et al. 2009, Park et al. 2009, Rzigalinski & Strobl 2009).”
Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents
Souza, G. R., Christianson, D. R., Staquicini, F. I., Ozawa, M. G., Snyder, E. Y., Sidman, R. L., Miller, J. H., Arap, W., & Pasqualini, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509739103 · Cited by 264 · cited 1×
“…be customized in the range of 2–100 nm and their surface properties are amenable to the introduction of functional groups for conjugation of targeting ligands (Tkachenko et al. 2004, Souza et al. 2006, Berry et al. 2007, Oyelere et al. 2007, Jiang et al. 2008, Nativo et al. 2008) (see Table II).”
BackgroundPhototriggering of liposomal drug delivery systems
Shum, P., Kim, J.-M., & Thompson, D. H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00232-0 · Cited by 255 · cited 6×
“The concept of photocleavable lipids has been in existence for decades (Zhang & Smith 1999, Mueller et al. 2000, Shum et al. 2001, varez-Lorenzo et al. 2009).”
BackgroundInfluentialFenske, D. B., & Cullis, P. R. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.25 · Cited by 253
Gold nanoparticles enable selective light-induced contents release from liposomes
Paasonen, L., Laaksonen, T., Johans, C., Yliperttula, M., Kontturi, K., & Urtti, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.009 · Cited by 252 · cited 3×
“Therefore, light-induced heating of AuNSTs -liposome systems by UV, visible and near-infrared to release liposome-entrapped drugs and pharmaceuticals is drawing considerable interest (Paasonen et al. 2007, Wu et al. 2008a, Anderson et al. 2010).”
BackgroundMethodDas, M., Sanson, N., Fava, D., & Kumacheva, E. (2007) · Langmuir · doi:10.1021/la061596s · Cited by 249 · cited 1×
“Near IR-based drug release (using the AuNP) has been demonstrated for polymeric carriers (Radt et al. 2004, Goodwin et al. 2005, Skirtach et al. 2005, Das et al. 2007), and these systems are currently in the developmental stage (Portney & Ozkan 2006).”
BackgroundOptical excitation and detection of vapor bubbles around plasmonic nanoparticles
Lapotko, D. (2009) · Optics Express · doi:10.1364/oe.17.002538 · Cited by 238 · cited 5×
“PNBs have outstanding optical scattering properties that surpass those of AuNPs and fluorescent markers and can serve to control the release process.”
BackgroundInfluentialBubble collapse near a solid boundary: a numerical study of the influence of viscosity
POPINET, S., & ZALESKI, S. (2002) · Journal of Fluid Mechanics · doi:10.1017/s002211200200856x · Cited by 235 · cited 1×
“Since irradiation of HGNs is likely to produce localized heating within the vicinity of HGN, this temperature gradient was proposed to produce unstable vapor microbubbles leading to transient cavitation by the mechanical and thermal effects (Pecha & Gompf 2000, Popinet & Zaleski 2002).”
BackgroundPlasmonic Nanosensors for Imaging Intracellular Biomarkers in Live Cells
Kumar, S., Harrison, N., Richards-Kortum, R., & Sokolov, K. (2007) · Nano Letters · doi:10.1021/nl070365i · Cited by 232 · cited 1×
“…may serve as good tools for in vivo cell imaging, biosensing, and drug and/or gene delivery (Markowitz et al. 1999, Sandhu et al. 2002, Sokolov et al. 2003, Regev et al. 2004, Shukla et al. 2005, Bergen et al. 2006a, Han et al. 2006, Kneipp et al. 2006, Kumar et al. 2007, Chithrani et al. 2010).”
MethodBergen, J. M., von Recum, H. A., Goodman, T. T., Massey, A. P., & Pun, S. H. (2006) · Macromolecular Bioscience · doi:10.1002/mabi.200600075 · Cited by 225 · cited 2×
“Among various metal ionnanostructures, gold nanostructures (AuNSTs) have been extensively investigated as a model platform for biomedical research (Bergen et al. 2006b).”
BackgroundMethodFolate-Mediated Targeting of Therapeutic and Imaging Agents to Cancers
Reddy, J. A., & Low, P. S. (1998) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v15.i6.20 · Cited by 219
Park, S.-H., Oh, S.-G., Mun, J.-Y., & Han, S.-S. (2006) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2006.01.006 · Cited by 212 · cited 2×
“…(AuNP/HGNs) can be encapsulated into other nanoparticles such as liposomes (Markowitz et al. 1999, Faure et al. 2003, Regev et al. 2004, Park et al. 2006) and polymeric matrices (Mayer & Mark 1997, Cole et al. 1999, Gittins & Caruso 2001) making them suitable for biological…”
BackgroundPhotodynamic Therapy of Skin Cancers: Sensitizers, Clinical Studies and Future Directives
De Rosa, F. S., & Bentley, M. V. L. B. (2000) · Pharmaceutical Research · doi:10.1023/a:1007612905378 · Cited by 211 · cited 1×
“The majority of photosensitizing agents fall into one of four categories: porphyrin derivatives, chlorins, phthalocyanines, and porphycenes (Figure 1) (De Rosa & Bentley 2000).”
BackgroundCellular uptake and transport of gold nanoparticles incorporated in a liposomal carrier
Chithrani, D. B., Dunne, M., Stewart, J., Allen, C., & Jaffray, D. A. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.009 · Cited by 187 · cited 2×
“One such metal, gold has been recently tested (Chithrani et al. 2010).”
BackgroundMethodStover, T. C., Sharma, A., Robertson, G. P., & Kester, M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1770 · Cited by 179
Liposomal Nanomedicines: An Emerging Field
Fenske, D. B., Chonn, A., & Cullis, P. R. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310960 · Cited by 168 · cited 1×
“E-mail: apuri@helix.nih.gov ISSN 0968-7688 print/ISSN 1464-5203 online 2010 Informa UK, Ltd. DOI: 10.3109/09687688.2010.507788 (major components of biological membranes) (Fenske et al. 2008, Fenske & Cullis 2008).”
InfluentialLavi, A., Weitman, H., Holmes, R. T., Smith, K. M., & Ehrenberg, B. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)75557-4 · Cited by 166 · cited 1×
“…(Regen et al. 1981), photosensitization by membrane anchored hydrophobic (Chowdhary et al. 1993, Bisby et al. 1999a, Bisby et al. 2000b, Lavi et al. 2002, Chandra et al. 2005, Chandra et al. 2006), or water soluble probes (Yavlovich et al. 2009), photo-isomerization (Morgan et al.…”
BackgroundOptimization of Plasmonic Heating by Gold Nanospheres and Nanoshells
Harris, N., Ford, M. J., & Cortie, M. B. (2006) · The Journal of Physical Chemistry B · doi:10.1021/jp0606208 · Cited by 160 · cited 1×
“Most of the absorbed energy is converted to heat while a part of it is emitted as photoluminescence (Wilcoxon et al. 1998, Harris et al. 2006).”
BackgroundSynthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome
Negussie, A. H., Miller, J. L., Reddy, G., Drake, S. K., Wood, B. J., & Dreher, M. R. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.031 · Cited by 156 · cited 1×
“It is important to note that thermosensitive liposomes (currently in Phase 3 clinical trials and first described in the late 1970s) are thus far the best studied example of triggerable nanoparticles (Needham & Dewhirst 2001, Negussie et al. 2010).”
BackgroundImproved Oral Delivery of Paclitaxel Following Administration in Nanoemulsion Formulations
Tiwari, S. B., & Amiji, M. M. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.440 · Cited by 139
Multiple Lipid Compartments Slow Vesicle Contents Release in Lipases and Serum
Boyer, C., & Zasadzinski, J. A. (2007) · ACS Nano · doi:10.1021/nn7002025 · Cited by 132
Triggerable plasmalogen liposomes: improvement of system efficiency
Thompson, D. H., Gerasimov, O. V., Wheeler, J. J., Rui, Y., & Anderson, V. C. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00210-3 · Cited by 127 · cited 1×
“These sensitizing agents absorb between 630–820 nm photo-triggering of liposomes and release of contents (Thompson et al. 1996).”
BackgroundLight-Triggered Molecule-Scale Drug Dosing Devices
McCoy, C. P., Rooney, C., Edwards, C. R., Jones, D. S., & Gorman, S. P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073053q · Cited by 126 · cited 1×
“Therefore current light-guided therapy technologies have proved tobe successful for skin-relateddiseases (Donnelly et al. 2006a,Mccoy et al. 2007) as well for oral treatments (Donnelly et al. 2006b), primarily because tissue depth was not a limitation.”
BackgroundNear-infrared fluorescent probes for imaging vascular pathophysiology
Klohs, J., Wunder, A., & Licha, K. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0702-7 · Cited by 125 · cited 1×
“Wavelength sources below 700 nm cannot penetrate deeply into tissues, becauseof scattering and ahigh level of endogenous absorbers, such as oxy- and deoxyhemoglobin, lipids and water (Klohs et al. 2008).”
BackgroundPhotosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms
Sibani, S. A., McCarron, P. A., Woolfson, A. D., & Donnelly, R. F. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802444673 · Cited by 125
Current Dendrimer Applications in Cancer Diagnosis and Therapy
Majoros, I., Williams, C., & Baker, J. R. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608785849049 · Cited by 122 · cited 1×
“Some widely examined nanocarriers aimed at delivering either DNA, pharmaceuticals and/or imaging agents include dendrimers (Tomalia et al. 2007, Majoros et al. 2008), nano-gold shells (Liao 2007, Bakri et al. 2008), nanoemulsions (Tiwari & Amiji 2006), drug-polymer conjugates (Reddy & Low 1998,…”
BackgroundAntitumor Effect of Paclitaxel-Loaded PEGylated Immunoliposomes Against Human Breast Cancer Cells
Yang, T., Choi, M.-K., Fu-de, C., Lee, S. J., Chung, S., Shim, C., & Kim, D. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9425-y · Cited by 119 · cited 1×
“Nano-drug delivery systems coupled with site-specific targeting ligands constitute a promising system to boost efficacy and bioavailability of existing drugs and pharmaceuticals (Allen 1997, Allen & Cullis 2004, Torchilin 2007, Yang et al. 2007, Wang et al. 2009).”
BackgroundTransferrin-Conjugated Liposome Targeting of Photosensitizer AlPcS4 to Rat Bladder Carcinoma Cells
Derycke, A. S. L., Kamuhabwa, A., Gijsens, A., Roskams, T., De Vos, D., Kasran, A., Huwyler, J., Missiaen, L., & de Witte, P. A. M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh314 · Cited by 115 · cited 3×
“Derycke and colleagues (Derycke et al. 2004) took advantage of the upregulation of transferrin receptors on tumor cells, and conjugated the transferrin molecule to PEGylated liposomes loaded with the photosensitizer aluminum phthalocyanine tetrasulfonate (AlPCS4) (Derycke et al.”
BackgroundInfluentialOptically guided controlled release from liposomes with tunable plasmonic nanobubbles
Anderson, L. J. E., Hansen, E., Lukianova‐Hleb, E. Y., Hafner, J. H., & Lapotko, D. O. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.012 · Cited by 115 · cited 3×
“Therefore, light-induced heating of AuNSTs -liposome systems by UV, visible and near-infrared to release liposome-entrapped drugs and pharmaceuticals is drawing considerable interest (Paasonen et al. 2007, Wu et al. 2008a, Anderson et al. 2010).”
BackgroundMethodElongated supramolecular assemblies in drug delivery
Zarif, L. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00010-x · Cited by 110 · cited 1×
“…have been exploited for potential biological applications that include functionalized polymerized vesicles for vascular targeted molecular imaging (Li & Bednarski 2002), candidates for oral vaccine preparations (Alonso-Romanowski et al. 2003), and DNA delivery (Zarif 2002, Chiaramoni et al. 2007).”
BackgroundStover, T. C., Kim, Y. S., Lowe, T. L., & KESTER, M. A. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.037 · Cited by 109
A Novel Approach to a Bifunctional Photosensitizer for Tumor Imaging and Phototherapy
Chen, Y., Gryshuk, A. L., Achilefu, S., Ohulchanskyy, T. Y., Potter, W. R., Zhong, T., Morgan, J., Chance, B., Prasad, P. N., Henderson, B. W., et al. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050177o · Cited by 104 · cited 1×
“For example the hydrophobic nature of most photosensitizing agent makes them highly susceptible to aggregation in aqueous solutions, and therefore also limits their efficiency and delivery in the body (Chen et al. 2005a, Chen et al. 2005b).”
BackgroundWavelength-Programmed Solute Release from Photosensitive Liposomes
Bisby, R. H., Mead, C., & Morgan, C. G. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3456 · Cited by 104 · cited 2×
“The acyl chains are compact and organized in closely packed liposomes in the trans form that is thermodynamically preferable (Bisby et al. 2000a, Bisby et al. 2000b).”
BackgroundVisible-Light-Stimulated Destabilization of PEG-Liposomes
Mueller, A., Bondurant, B., & O’Brien, D. F. (2000) · Macromolecules · doi:10.1021/ma000055l · Cited by 104 · cited 2×
“The concept of photocleavable lipids has been in existence for decades (Zhang & Smith 1999, Mueller et al. 2000, Shum et al. 2001, varez-Lorenzo et al. 2009).”
BackgroundCole, D. H., Shull, K. R., Baldo, P. M., & Rehn, L. E. (1999) · Macromolecules · doi:10.1021/ma981252b · Cited by 99 · cited 1×
“…(AuNP/HGNs) can be encapsulated into other nanoparticles such as liposomes (Markowitz et al. 1999, Faure et al. 2003, Regev et al. 2004, Park et al. 2006) and polymeric matrices (Mayer & Mark 1997, Cole et al. 1999, Gittins & Caruso 2001) making them suitable for biological applications.”
BackgroundBerry, C. C., de la Fuente, J. M., Mullin, M., Wai Ling Chu, S., & Curtis, A. S. G. (2007) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2007.908973 · Cited by 97 · cited 1×
“…be customized in the range of 2–100 nm and their surface properties are amenable to the introduction of functional groups for conjugation of targeting ligands (Tkachenko et al. 2004, Souza et al. 2006, Berry et al. 2007, Oyelere et al. 2007, Jiang et al. 2008, Nativo et al. 2008) (see Table II).”
BackgroundActive Uptake of Drugs into Photosensitive Liposomes and Rapid Release on UV Photolysis ¶
Bisby, R. H., Mead, C., & Morgan, C. G. (2000) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2000)0720057auodip2.0.co2 · Cited by 96
Photoinduced destabilization of liposomes
Lamparski, H. G., Liman, U., Barry, J., Frankel, D. A., Ramaswami, V., Brown, M. F., & O’Brien, D. F. (1992) · Biochemistry · doi:10.1021/bi00118a008 · Cited by 89 · cited 1×
“Elegant studies by O’Brien and colleagues previously reported that UV light-induced photopolymerization of liposomes containing bis-sorbyl phosphatidylcholine (bis-SorbPC) results in leakage of liposome-entrapped contents (Lamparski et al. 1992, Bondurant & O’Brien 1998, Mueller et al. 2000).”
BackgroundFormulation of photocleavable liposomes and the mechanism of their content release
Chandra, B., Subramaniam, R., Mallik, S., & Srivastava, D. K. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b518359f · Cited by 87 · cited 4×
“…by membrane anchored hydrophobic (Chowdhary et al. 1993, Bisby et al. 1999a, Bisby et al. 2000b, Lavi et al. 2002, Chandra et al. 2005, Chandra et al. 2006), or water soluble probes (Yavlovich et al. 2009), photo-isomerization (Morgan et al. 1995), photooxidation (Shum et al. 2001),…”
BackgroundInfluentialKronberg, B., Dahlman, A., Carlfors, J., Karlsson, J. E., & Artursson, P. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790803 · Cited by 81 · cited 1×
“The primary factors involved in destabilization of liposomes resulted from interactions between liposomal lipids with serum components (Kronberg et al. 1990).”
BackgroundSpontaneous Formation of Silver Nanoparticles in Multilamellar Vesicles
Faure, C., Derré, A., & Néri, W. (2003) · The Journal of Physical Chemistry B · doi:10.1021/jp027449u · Cited by 71 · cited 1×
“Gold nanostructures (AuNP/HGNs) can be encapsulated into other nanoparticles such as liposomes (Markowitz et al. 1999, Faure et al. 2003, Regev et al. 2004, Park et al. 2006) and polymeric matrices (Mayer & Mark 1997, Cole et al. 1999, Gittins & Caruso 2001) making them suitable for biological…”
BackgroundPolymerized phosphatidyl choline vesicles. Stabilized and controllable time-release carriers
Regen, S. L., Singh, A., Oehme, G., & Singh, M. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(81)80020-4 · Cited by 71 · cited 2×
“Light-triggered release of liposomal drugs involves modified phospholipid molecules, that undergo either photopolymerization (Regen et al. 1981), photosensitization by membrane anchored hydrophobic (Chowdhary et al. 1993, Bisby et al. 1999a, Bisby et al. 2000b, Lavi et al. 2002, Chandra et al.…”
BackgroundMethodRegev, O., Backov, R. V., & Faure, C. (2004) · Chemistry of Materials · doi:10.1021/cm049251n · Cited by 71 · cited 2×
“…may serve as good tools for in vivo cell imaging, biosensing, and drug and/or gene delivery (Markowitz et al. 1999, Sandhu et al. 2002, Sokolov et al. 2003, Regev et al. 2004, Shukla et al. 2005, Bergen et al. 2006a, Han et al. 2006, Kneipp et al. 2006, Kumar et al. 2007, Chithrani et al. 2010).”
BackgroundMethodABSENCE OF HISTOLOGIC RETINAL TOXICITY OF INTRAVITREAL NANOGOLD IN A RABBIT MODEL
BAKRI, S. J., PULIDO, J. S., MUKHERJEE, P., MARLER, R. J., & MUKHOPADHYAY, D. (2008) · Retina · doi:10.1097/iae.0b013e3180dc9360 · Cited by 63 · cited 1×
“…either DNA, pharmaceuticals and/or imaging agents include dendrimers (Tomalia et al. 2007, Majoros et al. 2008), nano-gold shells (Liao 2007, Bakri et al. 2008), nanoemulsions (Tiwari & Amiji 2006), drug-polymer conjugates (Reddy & Low 1998, Leamon & Low 2001), drug-antibody conjugates…”
BackgroundLiu, X.-M., Yang, B., Wang, Y.-L., & Wang, J. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.10.016 · Cited by 61 · cited 1×
“In 2005, Liu and colleagues reported the synthesis of a series of photo-isomerizable cholesterol derivatives (Figure 6B); these molecules may have potential for light-triggered delivery, although no biological data have been reported (Liu et al. 2005).”
BackgroundAckermann, G., Hartmann, M., Scherer, K., Lang, E. W., Hohenleutner, U., Landthaler, M., & Bäumler, W. (2002) · Lasers in Medical Science · doi:10.1007/s101030200013 · Cited by 59 · cited 1×
“Since high energy/long wavelength sources are a requirement for treatment of deep tissues (Ackermann et al. 2002), currently available UV/visible light-photoactivabledrugdelivery systems (described in section 5b) are not suitable for clinical applications.”
BackgroundZhang, Z., & Smith, B. D. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990087h · Cited by 58
Self-citationChiral tubule self-assembly from an achiral diynoic lipid
Pakhomov, S., Hammer, R. P., Mishra, B. K., & Thomas, B. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0030051100 · Cited by 53 · cited 2×
“…phospholipid (1,2 bis(tricosa-10,12-diynoyl)-sn-glycero-3-phosphocholine (DC8,9PC, Figure 6D, i), is present in lower organisms (Figure 6D, ii) (Pakhomov et al. 2003), and has been shown to uniquely assemble into the lipid bilayer due to the presence of triple bonds in the fatty acyl chains.”
BackgroundCharacterization of diacetylenic liposomes as carriers for oral vaccines
Alonso, S. D. V., Chiaramoni, N. S., Lioy, V. S., Gargini, R., Viera, L., & Taira, M. C. (2003) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00190-1 · Cited by 49
Photoinduced Destabilization of Sterically Stabilized Liposomes
Bondurant, B., & O’Brien, D. F. (1998) · Journal of the American Chemical Society · doi:10.1021/ja983112n · Cited by 49 · cited 1×
“Elegant studies by O’Brien and colleagues previously reported that UV light-induced photopolymerization of liposomes containing bis-sorbyl phosphatidylcholine (bis-SorbPC) results in leakage of liposome-entrapped contents (Lamparski et al. 1992, Bondurant & O’Brien 1998, Mueller et al. 2000).”
BackgroundShackley, D., Whitehurst, C., Moore, J., George, N. J. R., Betts, C. D., & Clarke, N. W. (2000) · British Journal of Urology · doi:10.1046/j.1464-410x.2000.00872.x · Cited by 43 · cited 1×
“Shackley and colleagues (Shackley et al. 1999, Shackley et al. 2000) reported that laser sourceswithwavelengths of 633–693nmwere potentially applicable for bladder PDT. Future perspectives of photosensitive lipid-based nanoparticles in drug delivery It can be imagined that nanotechnology platforms…”
BackgroundLipid Nanotubes: Formation, Templating Nanostructures and Drug Nanocarriers
Zhou, Y. L. (2008) · Critical reviews in solid state and materials sciences/CRC critical reviews in solid state and materials sciences · doi:10.1080/10408430802408639 · Cited by 42 · cited 1×
“…feature multifunctional nanoparticles with imaging molecules, a pay-load of drugs, targeting ligands, destabilization elements as well as sensors that probe the efficacy of the drug in real time (Allen & Cullis 2004, Alonso 2004, Torchilin 2005, Alaouie & Sofou 2008, Ganta et al. 2008, Zhou 2008).”
BackgroundVascular‐targeted molecular imaging using functionalized polymerized vesicles
Li, K. C., & Bednarski, M. D. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10174 · Cited by 35 · cited 1×
“…have been exploited for potential biological applications that include functionalized polymerized vesicles for vascular targeted molecular imaging (Li & Bednarski 2002), candidates for oral vaccine preparations (Alonso-Romanowski et al. 2003), and DNA delivery (Zarif 2002, Chiaramoni et al. 2007).”
BackgroundPhotosensitiser delivery for photodynamic therapy. Part 1: Topical carrier platforms
Donnelly, R. F., McCarron, P. A., Morrow, D. I. J., Sibani, S. A., & Woolfson, A. D. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.7.757 · Cited by 33
Shackley, D., Whitehurst, C., Clarke, N. W., Betts, C. D., & Moore, J. V. (1999) · Journal of the Royal Society of Medicine · doi:10.1177/014107689909201106 · Cited by 33
The Effect of Membrane Charge on Gold Nanoparticle Synthesis via Surfactant Membranes
Markowitz, M. A., Dunn, D. N., Chow, G. M., & Zhang, J. (1999) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1998.5932 · Cited by 26 · cited 2×
“AuNSTs are also biocompatible and, therefore, may serve as good tools for in vivo cell imaging, biosensing, and drug and/or gene delivery (Markowitz et al. 1999, Sandhu et al. 2002, Sokolov et al. 2003, Regev et al. 2004, Shukla et al. 2005, Bergen et al. 2006a, Han et al. 2006, Kneipp et al. 2006,…”
BackgroundDithiane-Based Photolabile Amphiphiles: Toward Photolabile Liposomes 1 , 2
Li, Z., Wan, Y., & Kutateladze, A. G. (2003) · Langmuir · doi:10.1021/la034188m · Cited by 25 · cited 2×
“The same group also synthesized nitropyridine-based self-sensitized photolabile amphiphiles (Figure 6C, i) (Li et al. 2003).”
BackgroundTopical Bioadhesive Patch Systems Enhance Selectivity of Protoporphyrin IX Accumulation
Donnelly, R. F., Ma, L., Juzenas, P., Lani, V., McCarron, P. A., Woolfson, A. D., & Moan, J. (2006) · Photochemistry and Photobiology · doi:10.1562/2005-08-08-ra-641 · Cited by 22 · cited 1×
“Therefore current light-guided therapy technologies have proved tobe successful for skin-relateddiseases (Donnelly et al. 2006a,Mccoy et al. 2007) as well for oral treatments (Donnelly et al. 2006b), primarily because tissue depth was not a limitation.”
BackgroundFormation of Stable Nanocapsules from Polymerizable Phospholipids
Lawson, G. E., Lee, Y., & Singh, A. (2003) · Langmuir · doi:10.1021/la034434u · Cited by 21 · cited 4×
“2003b) and N-(4-Vinylbenzoyl) head group (Lawson et al. 2003a) are shown in Figure 4.”
BackgroundInfluentialFacilitated Delivery of ALA to Inaccessible Regions via Bioadhesive Patch Systems
McCarron, P. A., Ma, L., Juzenas, P., Lani, V., Woolfson, A. D., Zawislak, A. A., & Moan, J. E. (2006) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.v25.i1-2.240 · Cited by 20 · cited 1×
“Therefore current light-guided therapy technologies have proved tobe successful for skin-relateddiseases (Donnelly et al. 2006a,Mccoy et al. 2007) as well for oral treatments (Donnelly et al. 2006b), primarily because tissue depth was not a limitation.”
BackgroundWang, S. X., Bao, A., Phillips, W. T., Goins, B., Herrera, S. J., Santoyo, C., Miller, F. R., & Otto, R. A. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.02.009 · Cited by 20 · cited 1×
“Nano-drug delivery systems coupled with site-specific targeting ligands constitute a promising system to boost efficacy and bioavailability of existing drugs and pharmaceuticals (Allen 1997, Allen & Cullis 2004, Torchilin 2007, Yang et al. 2007, Wang et al. 2009).”
BackgroundChen, Y., Miclea, R. D., Srikrishnan, T., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.019 · Cited by 19 · cited 1×
“For example the hydrophobic nature of most photosensitizing agent makes them highly susceptible to aggregation in aqueous solutions, and therefore also limits their efficiency and delivery in the body (Chen et al. 2005a, Chen et al. 2005b).”
BackgroundLiao, J. Y. (2007) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2007.01.006 · Cited by 18 · cited 1×
“…at delivering either DNA, pharmaceuticals and/or imaging agents include dendrimers (Tomalia et al. 2007, Majoros et al. 2008), nano-gold shells (Liao 2007, Bakri et al. 2008), nanoemulsions (Tiwari & Amiji 2006), drug-polymer conjugates (Reddy & Low 1998, Leamon & Low 2001), drug-antibody…”
BackgroundSingh, A., & Gaber, B. P. (1988) · Springer eBooks · doi:10.1007/978-1-4684-5610-3_18 · Cited by 7
Park, H., Jung, S., Kim, D., Shin, S., & Cho, C. (2009) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826070802671432 · Cited by 1 · cited 1×
“…et al. 2008), nano-gold shells (Liao 2007, Bakri et al. 2008), nanoemulsions (Tiwari & Amiji 2006), drug-polymer conjugates (Reddy & Low 1998, Leamon & Low 2001), drug-antibody conjugates (Jaracz et al. 2005), and quantum dots (Cormode et al. 2009, Park et al. 2009, Rzigalinski & Strobl 2009).”
Cited by
Nanoparticles in Photodynamic Therapy
Lucky, S. S., Soo, K. C., & Zhang, Y. (2015) · Chemical Reviews · doi:10.1021/cr5004198 · Cited by 2,980
Azobenzene photoswitches for biomolecules
Beharry, A. A., & Woolley, G. A. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15023e · Cited by 1,851
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864
Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials
Weinstain, R., Slanina, T., Kand, D., & Klán, P. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00663 · Cited by 642
Metadata
- Authors
- Yavlovich, A., Smith, B., Gupta, K., Blumenthal, R., & Puri, A.
- Venue
- Molecular Membrane Biology
- Publisher
- Informa UK Limited
- Published
- 2010-10
- Volume
- 27
- Issue
- 7
- Pages
- 364-381
- ISSN
- 0968-7688 (ISSN-L)
- 1464-5203
- OpenAlex
- W1977246666
- Cited by
- 178
- References
- 114
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.